Search Results
1 - 12 of 13 matches
Sort by:
STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors
Presenter:
Sanjit Jolly
October 25, 2023
PCSK9 Inhibitors for the Interventionalist: Which Patients Do We Choose and How Do We Use?
Presenter:
Matthew J. Budoff
November 1, 2019
Role of PCSK9 Inhibitors Post-PCI and ACS
Presenter:
Marc Bonaca
September 26, 2019
PCSK9 Inhibitors - Are They Worth The Money?
Presenter:
Michael J. Blaha
November 16, 2017
Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors
Presenter:
Evan A. Stein, Gregg W. Stone, Peter H. Stone
November 1, 2017
Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?
Presenter:
Gregg W. Stone, Ron Waksman, Sanjit S. Jolly
November 1, 2016
Hyperlipidemic Therapy: From Statins to PCSK9 Inhibitors
Presenter:
George D. Dangas, Joshua W. Knowles, Paul A. Gurbel
October 13, 2015
Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis?
Presenter:
Gregg W. Stone, Philippe Gabriel Steg, Renu Virmani
October 12, 2015
PCSK9 Inhibitors: Comparison of Agents and a Systematic Review
Presenter:
Evan A. Stein, Harvey D. White, Ori Ben-Yehuda, Roxana Mehran
September 15, 2014
Systemic Therapies for the At-Risk Patient: From Darapladib to Anti-inflammatories and PCSK9 Inhibitors
Presenter:
Harvey D. White, Patrick W. Serruys, Valentin Fuster
September 14, 2014